Lonza Group (OTCMKTS:LZAGY) Upgraded to “Strong-Buy” at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Lonza Group (OTCMKTS:LZAGY) to a strong-buy rating in a report released on Wednesday morning, Zacks.com reports.

Separately, Berenberg Bank raised shares of Lonza Group to a strong-buy rating in a report on Sunday, June 23rd.

Lonza Group Stock Up 1.0 %

Shares of LZAGY stock opened at $61.37 on Wednesday. The stock has a 50-day moving average of $63.79 and a 200-day moving average of $59.56. Lonza Group has a one year low of $34.19 and a one year high of $67.00.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.